Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Altaire Pharmaceuticals, Inc.
FDA Inspection
•Altaire Pharmaceuticals, Inc.•March 9, 2017

Altaire Pharmaceuticals, Inc. – FDA Inspection, Mar 9, 2017

Record Details

This FDA Inspection record concerns Altaire Pharmaceuticals, Inc., with an inspection on March 9, 2017, issued by the Center for Veterinary Medicine, covering veterinary.

Company
Altaire Pharmaceuticals, Inc.
Inspection Date
March 9, 2017
Product Type
Veterinary
Office
Center for Veterinary Medicine
Person
  • Robert C. Horan (FDA Associated Person)
View Company Profile

ID · f51d435b-4a99-4725-821e-eb2163b6329a

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1005208
FDA center
Animal Drugs & Feeds
Project area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Outcome
Form 483 issued

FDA Citations

5
  1. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  2. 21 CFR 211.160(b)Scientifically sound laboratory controls
  3. 21 CFR 211.194(a)Complete test data included in records
  4. 21 CFR 211.113(b)Procedures for sterile drug products
  5. 21 CFR 211.198(a)Complaints reviewed by Quality Control Unit

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Altaire Pharmaceuticals, Inc.

13
DateClassificationOfficeProject area
April 21, 2026Not classifiedNew York District OfficeDrug Quality Assurance
October 21, 2024NAICenter for Devices and Radiological HealthCompliance: Devices
February 11, 2022OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
April 19, 2019OAICenter for Veterinary MedicineGeneric Drug Evaluation
December 15, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 13 other inspections on the company page
Other documents for Altaire Pharmaceuticals, Inc.
  • FDA Inspection 1314330 - 2026-04-21
  • FDA Inspection 1251507 - 2024-10-21
  • FDA Inspection 1162640 - 2022-02-11
  • FDA Inspection 1089315 - 2019-04-19
  • FDA Inspection 955795 - 2015-12-15

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Altaire Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.